Royalty Pharma
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Royalty Pharma's balance sheet done over the years? Its assets were worth $16,381,851,000 last year, which is less than in the previous period. 38% of Royalty Pharma’s total assets is currently financed by debt. Its liabilities reached the amount of $6,297,562,000, which means an decrease by -14% compared compared to last year.
Debt to Assets
| 2015 | 10815682000 | 6.11B | 56.57% |
|---|---|---|---|
| 2017 | 11373532000 | 6.90B | 60.7% |
| 2018 | 11370147000 | 6.81B | 59.96% |
| 2019 | 12449895000 | 6.30B | 50.67% |
| 2020 | 21097036000 | 6.12B | 29.03% |
| 2021 | 17515865000 | 7.26B | 41.49% |
| 2022 | 16813466000 | 7.28B | 43.35% |
| 2023 | 16381851000 | 6.29B | 38.44% |
RPRX Balance Sheet (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | |
|---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | 477.01M | 1.71B | 1.54B | 1.00B | 283.68M | 1.92B | 1.38B | 1.72B |
Short term investments | 18.3M | 717.04M | 1.26B | 983M | 509.53M | 461.82M | 0 | 0 |
Net receivables | 775.08M | 36.59M | 68.30M | 39.16M | 38.76M | 198.62M | 0 | 0 |
Inventory | 0 | 1 | 1 | 657.13M | 0 | 19.19M | 0 | 0 |
Other current assets | 3.79M | 90.52M | 6.63M | 8.59M | 92K | 4.69M | 1.56B | 1.32B |
Total current assets | 1.27B | 2.55B | 2.87B | 2.69B | 832.07M | 2.60B | 2.94B | 3.04B |
Non-current assets: | ||||||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 1.77M | 14.5M | 5.67M | 28.66M | 51.72M | 75.64M | 0 | 6.94B |
Long term investments | 1.01B | 14.22B | 14.62B | 13.26B | 11.47B | 8.66B | 0 | 0 |
Other non-current assets | 14.09B | 15.12M | 4.14M | 28.59M | 87.95M | 19.11M | 0 | 822.27M |
Total non-current assets | 15.10B | 14.25B | 14.63B | 13.32B | 11.61B | 8.76B | 8.42B | 7.77B |
Total assets | 16.38B | 16.81B | 17.51B | 21.09B | 12.44B | 11.37B | 11.37B | 10.81B |
Liabilities | ||||||||
| Current liabilities: | ||||||||
Accounts payable | ||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 31.04M | 0 | 0 | 0 |
Short term debt | 0 | 997.51M | 0 | 0 | 281.98M | 281.43M | 280.92M | 184.38M |
Total current liabilities | 161.37M | 1.16B | 171.25M | 307.88M | 333.41M | 580.17M | 383.41M | 314.39M |
| Non-current liabilities: | ||||||||
Long term debt | 6.13B | 6.11B | 7.09B | 5.81B | 5.95B | 6.23B | 6.52B | 5.80B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 900K | 2.5M | -7.09B | -5.81B | 18.90M | 0 | 0 | 0 |
Total non-current liabilities | 6.13B | 6.12B | 7.09B | 5.81B | 5.97B | 6.23B | 6.52B | 5.80B |
Total liabilities | 6.29B | 7.28B | 7.26B | 6.12B | 6.30B | 6.81B | 6.90B | 6.11B |
| Data source | Data source | Data source | Data source |